Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06783049

Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent Management System

The purpose of this study is to develop a digital health-based intelligent management system for the secondary prevention of ischemic stroke and to evaluate its effectiveness through a multicenter randomized controlled trial, assessing its health economic value.

Participants will receive usual care after discharge (control group) or be managed with a WeChat-based intelligent management system after discharge (intervention group).

At one year, all patients will undergo face-to-face follow-up to assess clinical events, medication adherence, and the achievement of target risk factor levels.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Beijing Tsinghua Changgung Hospital, Beijing, Beijing Municipality, China

Loading trial locations.

About this study

Before discharge, patients receive standard education on the secondary prevention of ischemic stroke from their physician, covering topics such as secondary prevention medications, risk factor management, lifestyle modifications, and rehabilitation. Additionally, the "Intelligent Management System," a WeChat-based applet, is activated for each patient. The system records basic patient information and integrates with mobile IoT devices, such as blood pressure monitors and glucose meters, allowing for self-monitoring of risk factors post-discharge. Based on international guidelines, high-level evidence, and the expertise of stroke specialists, a comprehensive clinical decision-making tree is established. This serves as the foundation for an AI feedback system that provides intelligent feedback on risk factor control and predicts recurrence risk. The patient interface includes educational content on ischemic stroke, risk factor management, lifestyle adjustments, and follow-up schedules post-discharge.

The system also features a physician interface, which enables attending doctors to offer online consultations, schedule face-to-face follow-up appointments, and manage patients long-term. Each patient is assigned to an "Online Stroke Care Team," which includes a "Health Management Officer" responsible for facilitating communication between the patient and the physician and providing basic health guidance. Additionally, an "Online Doctor" is available to answer stroke-related medical questions.

The Health Management Officer monitors patients' health data and arranges online or in-person consultations for those with poor adherence or suboptimal target achievement. Patient management is guided by the theory of health empowerment, creating an integrated online and offline ischemic stroke management intervention model.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18 years.
  • Patients diagnosed with acute ischemic stroke or transient ischemic attack.
  • Time from onset to enrollment ≤ 14 days.
  • Presence of at least one modifiable risk factor (hypertension, diabetes).
  • Ability to independently use a smartphone to complete system tasks upon discharge, or with the assistance of family members.
  • Signed informed consent by the patient or their family members.

Exclusion criteria

  • Patients already enrolled in other stroke-related healthcare quality improvement projects or clinical trials.
  • Patients or family members who refuse to sign the informed consent form.
  • Pregnant or breastfeeding women.

Treatment and study plan

Cerebrovascular Disease Secondary Prevention Smart Management System

Behavioral

The continuous post-discharge intervention for patients was conducted using the Cerebrovascular Disease Secondary Prevention Smart Management System. This system, integrated with a WeChat-based applet, records patients' basic information and connects with mobile IoT devices such as blood pressure monitors and glucose meters. This allows patients to self-monitor their risk factors post-discharge. Based on international guidelines, high-level evidence, and the clinical expertise of cerebrovascular specialists, a comprehensive clinical decision-making tree was developed. This serves as the foundation for an AI feedback system that provides intelligent feedback on risk factor control and predicts the risk of recurrence.

Primary outcomes

  1. Vascular events and all-causes death

    Time frame: From enrollment to 1 year follow-up

    Vascular and all-cause mortality events were collected for one year post-enrollment through face-to-face follow-ups and patient self-reports. Vascular events included stroke recurrence, transient ischemic attacks, myocardial infarction, vascular interventions or surgeries, and systemic embolism. If a patient experienced both a vascular event and death, only one event was recorded. In cases of multiple vascular events, only the first event was documented.

  2. Risk factor control rate

    Time frame: From enrollment to 1 year follow-up

    Risk factor control was defined as achieving glycated hemoglobin (HbA1c) ≤7% or blood pressure below the target set at discharge. If a patient had both hypertension and diabetes at enrollment, meeting the criteria for both conditions was considered two achieved targets. If the patient had only hypertension or diabetes at enrollment, meeting the target for the respective condition was considered one achieved target.

Secondary outcomes

  1. Readmission to hospital within 1 year

    Time frame: From enrollment to 1 year follow-up

  2. Stroke-related readmission

    Time frame: From enrollment to 1 year follow-up

  3. Direct medical costs

    Time frame: From enrollment to 1 year follow-up

  4. Rate of good adherence to secondary prevention medicine

    Time frame: From enrollment to 1 year follow-up

  5. Adverse drug reaction

    Time frame: From enrollment to 1 year follow-up

  6. Body mass index

    Time frame: From enrollment to 1 year follow-up

  7. Waist circumstance

    Time frame: From enrollment to 1 year follow-up

  8. Frequency of blood pressure monitoring

    Time frame: From enrollment to 1 year follow-up

    calculated as time/week

  9. Frequency of blood glucose monitoring

    Time frame: From enrollment to 1 year follow-up

    calculated as time/week

  10. Blood lipid levels

    Time frame: From enrollment to 1 year follow-up

    Included total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglyceridee

  11. Rehabilitation

    Time frame: From enrollment to 1 year follow-up

  12. Smoking

    Time frame: From enrollment to 1 year follow-up

  13. Alcohol

    Time frame: From enrollment to 1 year follow-up

  14. Regular exercise

    Time frame: From enrollment to 1 year follow-up

  15. Overall physical activity level

    Time frame: From enrollment to 1 year follow-up

    Assessed by IPAQ-S, calculated as MET-min/week

  16. Fatigue

    Time frame: From enrollment to 1 year follow-up

    Assessed by Fatigue Severity Scale (FSS). Fatigue was defined as total FSS score ≥36

Study contacts

Contact information is provided by the study sponsor or research team.

Chunjuan Wang, MD

CONTACT

[email protected]

86+18210100840

Zhiyuan Feng, MD

CONTACT

[email protected]

86+15801290121

Sponsors and collaborators

Lead sponsor

Beijing Tiantan Hospital

Other

Collaborators

  • BOE Technology Group Co., Ltd.
  • Beijing Tsinghua Chang Gung Hospital
  • First People's Hospital of Foshan
  • The First Hospital of Jilin University
  • The Second Affiliated Hospital of Fujian Medical University
  • The affiliated Hospital of Shihezi University
  • Xiangya Hospital of Zhongnan University

Registry information

Official study title

Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent System

Acronym: SPIRIT

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Jan 20, 2025
Registry last updated
Jan 21, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.